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Background: Amebic dysentery is caused by the protozoan parasite Entamoeba histolytica and the ingestion of
quadrinucleate cyst of E. histolytica from fecally contaminated food or water initiates infection. Excystation occurs in
the lumen of small intestine, where motile and potentially invasive trophozoites germinate from cysts. The ability of
trophozoites to interact and digest gut bacteria is apparently important for multiplication of the parasite and its
pathogenicity; however the contribution of resident bacterial flora is not well understood. We quantified the
population of Bacteroides, Bifidobacterium, Ruminococcus, Lactobacillus, Clostridium leptum subgroup, Clostridium
coccoides subgroup, Eubacterium, Campylobacter, Methanobrevibacter smithii and Sulphur reducing bacteria using
genus specific primers in healthy (N = 22) vs amebic patients (E. histolytica positive, N = 17) stool samples by
Real-time PCR.
Results: Absolute quantification of Bacteroides (p = .001), Closrtridium coccoides subgroup (p = 0.002), Clostridium
leptum subgroup (p = 0.0001), Lactobacillus (p = 0.037), Campylobacter (p = 0.0014) and Eubacterium (p = 0.038) show
significant drop in their population however, significant increase in Bifdobacterium (p = 0.009) was observed where
as the population of Ruminococcus (p = 0.33) remained unaltered in healthy vs amebic patients (E. histolytica
positive). We also report high prevalence of nimE gene in stool samples of both healthy volunteers and amebic
patients. No significant decrease in nimE gene copy number was observed before and after the treatment with
antiamebic drug.
Conclusions: Our results show significant alteration in predominant gut bacteria in E. histolytica infected individuals.
The frequent episodes of intestinal amoebic dysentery thus result in depletion of few predominant genera in gut
that may lead to poor digestion and absorption of food in intestine. It further disturbs the homeostasis between
gut epithelium and bacterial flora. The decrease in beneficial bacterial population gives way to dysbiosis of gut
bacteria which may contribute to final outcome of the disease. Increase in the copy number of nimE gene
harboring bacteria in our population reflects possible decrease in the availability of metronidazole drug during
treatment of amoebiasis.
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Entamoeba histolytica, a micro-aerophilic intestinal proto-
zoan parasite and the causative agent of invasive
amoebiasis (colitis and amoebic liver abscess), remains a
significant cause of morbidity and mortality in developing
countries [1]. It is well known that the parasite is con-
stantly interacting with the intestinal gut flora however
the contribution of the flora in the manifestation of the
disease is poorly understood. The human gastrointestinal* Correspondence: jpaul33@hotmail.com
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reproduction in any medium, provided the or(GI) tract is nutrient-rich environment packed with a
complex and dynamic consortia of trillions of microbes
[2].The vast majority reside in our colon where densities
approach 1011 - 1012 cells/ml, the highest density recorded
for any microbial habitat [3]. About 500–1000 bacterial
species colonize the adult intestine,with 30–40 species
comprising up to 97% of the total population [4,5].
Bacteroides, Bifidobacterium, Eubacterium, Clostridium,
Peptococcus, Peptostreptococcus, Lactobacillus and Rumi-
nococcus are considered to be predominant genera
whereas Enterococcus, Methanobrevibacter and sulphur
reducing bacteria (SRB) remain as the subdominantLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Verma et al. BMC Microbiology 2012, 12:183 Page 2 of 11
http://www.biomedcentral.com/1471-2180/12/183genera [6]. The entire system of the human gut microbiota
functions as a ‘microbial organ’ within the intestine, which
contributes to diverse mammalian processes including
protective functions against pathogens and immune-
system modulation, the metabolic function of fermenting
non-digestible dietary fiber, anaerobic metabolism of pep-
tides and proteins that results in the recovery of metabolic
energy for the host [7]. The microbial diversity of the
human gut is the result of co-evolution between microbial
communities and their hosts. Microbial community struc-
ture is a very important factor that can influence predis-
position to specific diseases in certain host contexts [8].
Ingestion of the cyst of E. histolytica through fecally
contaminated food or water initiates infection. Excysta-
tion in the intestinal lumen produces trophozoites and
colitis results when the trophozoites penetrate the
mucus layer and damages intestinal tissues [9]. The tro-
phozoites proliferate in lumen and phagocytose resident
flora. E. histolytica trophozoites are quite selective in re-
spect to their interactions with different bacterial species
and only those bacteria which have the appropriate rec-
ognition molecules get attached and ingested [10]. It has
been observed that the nuclear DNA content of E. histo-
lytica trophozoites growing in axenic cultures is at least
10 fold higher than in xenic cultures and re-association
of axenic cultures with their bacterial flora led to a re-
duction of DNA content attaining the original xenic
values indicating a flexible nature of the parasite genome
[11]. Fluctuations in gut flora have been reported both
in acute diarrhea and antibiotic associated diarrhea [12],
but very few reports are available on status of gut flora
in E. histolytica infected individuals. Earlier studies in
our laboratory [1] have recorded fluctuations in the gut
flora by a qualitative method during disease conditions.
5-Nitroimidazole drugs are still used as first line of
defense against amoebic and other infections caused by
anaerobes. These drugs are administered as pro drugs
and one electron reduction of nitro group converts the
pro drug into an active drug [13]. Enzymatic modifica-
tion mediated by nim-class of genes is a well characte-
rized resistance mechanism. Certain Bacteroides species
which are members of the normal colonic human micro-
flora harbor nim genes [14]. Our study is based on the
hypothesis that the Entamoeba histolytica (but not E.
dispar) is an invasive organism and invades the mucus
layer and subsequently the intestinal epithelium for
colonization using the pathogenic factors. In this context
we attempted to study the fluctuations in the gut micro-
biota that contributes to substantial metabolic changes
in E. histolytica infected individuals compared to healthy
individuals. In the present study we used Real Time PCR
for absolute quantification of predominant gut bacte-
rial population in E. histolytica patients suffering from
dysentery for 5–7 days. We also quantified the copynumber of nim gene in stool sample of healthy vs E. his-
tolytica patients.
Methods
Study subjects & fecal sample collection
Stool samples of healthy person (without any enteric di-
sease) were collected as controls from volunteers of a
community in Delhi. Initial survey involved discussion
with the focus group and informed consent was taken
from participating volunteers for the study. Volunteers
in age group of 21–40 year (mean age 31 year) were ran-
domly recruited. Subjects who have taken any antibiotic/
antiamoebic drug or suffered from any gastrointestinal
disorder in past one month before sample collection
were not included in the study. Twenty two stool sam-
ples were collected from healthy volunteers. Clinical
diagnosis of amoebic colitis was based on standard cri-
teria: patients experiencing days to weeks of dysentery
(stool with blood and mucus) or diarrhea with cramps
followed by abdominal pain and/or weight loss. The sub
acute onset of the disease was a helpful clue in the di-
fferential diagnosis because bacillary dysentery caused by
Shigella, Salmonella, Campylobacter and EHEC E. coli
mostly lead to a abrupt onset of the disease [15]. Since
we did not take samples from individuals administered
with any antibiotic, therefore cases of antibiotic asso-
ciated diarrhea were excluded. Stool samples of chronic/
acute diarrhea as diagnosed by Gastroenterologist were
collected from Gastroenterology department of All India
Institute of Medical Sciences & Safdarjung hospitals,
New Delhi. The samples were transported to the la-
boratory at 4°C within 2 hrs and stored at -20°C until
processed. The study was approved by the research
ethics board of respective institutes. The samples
(n = 550) were collected with the informed consent of
the patients.
Enrichment of entamoeba cysts
Cysts were enriched following the protocol of Knight
et al., 1976 [16] with slight modifications. Briefly, fecal
samples (1gm) were homogenized in 10 ml of autoclaved
distilled water, strained through cheesecloth in 50 ml fal-
con tube. This suspension was centrifuged at 2000 rpm
for 5 min and pellet was re-dissolved in 10 ml of 10%
formaldehyde. 3 ml of diethyl ether was added to the
tube and this mixture was vortexed and incubated at RT
for 30 min. The mixture was subjected to centrifuga-
tion at 2000 rpm for 5 min, supernatant was removed
and pellet was washed with double distilled water. The
Pellet containing concentrated cyst was re-dissolved in
400 μl T10E1 buffer. Cysts in T10E1 buffer was subjec-
ted to freeze-thaw cycle and thereafter to sonication
in order to obtain crude DNA for Dot-blot hybri-
dization experiment.
Verma et al. BMC Microbiology 2012, 12:183 Page 3 of 11
http://www.biomedcentral.com/1471-2180/12/183Screening of samples by dot blot hybridization
The crude cyst DNA was denatured by addition of
NaOH to final concentration of 0.25 N in a total volume
of 300 μl. The DNA was kept at room temperature for
30 minutes and then transferred on to ice. The GS +
nylon membrane of required size was cut and saturated
in 0.4 M Tris-Cl, pH 7.5 for 15 min and the DNA were
spotted on to the membrane with the help of mini-fold
apparatus from Whatman, Germany. The blots were air
dried and UV cross linked before hybridization. We used
4.5 kb rDNA fragment (EcoRI to Hind III site) from
HMe region of EhR1 (rDNA plasmid in HM1:IMSS
strain of E.histolytica) as probe for detection of Enta-
moeba positive samples that include both E.histolytica
and E. dispar (Figure 1A) [17].
Genomic DNA extraction
DNA was extracted from the Dot blot positive samples.
An aliquot of 200 mg stool sample was used for isolation
using QIAamp mini stool kit (QIAGEN,Germany) as per
manufacturer’s guidelines. While isolating DNA from
the stool samples through the above kit, pGEMT-easy
plasmid containg 240 bp fragment of glycoprotein B (gB)
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Figure 1 Screening of stool samples by Dot-Blot method. (A) Linear m
kb in size) common for both E. histolytica and E. dispar), E - EcoR1 site and
transcription units with various restriction sites and repeats (B) Representat
1 to 6 (column A-D) represent spots of DNA from stool samples. About 20
Row 7 was blank. Row 8 (column A) E. histolytica HM1: IMSS genomic DNA
positive control; (column C) E.Coli DH5α as negative control; (column D) Pla
triplicate. Experimental details are provided in material and methods.added in ASL buffer as internal control during the isola-
tion of genomic DNA [18].
PCR analysis of Dot blot positive samples
To differentiate Dot-blot positive samples into E. histolytica
and E. dispar, primers were designed from EhSINE2 for E.
histolytica and from 18 S and ITS2 region of rDNA circle
for E. dispar respectively (Figure 2A & B). Primer sequences
were as follows; Eh-F 5’-GTCAGAGACACCACATGAA-3’,
Eh-R 5’-GAGACCCCTTAAAGAAAC -CC-3’ and Ed-
F 5’-GAAGAAACATTGTTTCTAAATCCAA-3’ & Ed-R
5’-TTTATTAA CTC ACTTATA-3’ [19].
Primer designing for detection of predominant genera of
gut flora
Primer sets were designed to differentiate and quantitate
the following major anaerobic genera –Bacteroides, Clos-
tridium, Campylobacter, Bifidobacterium, Ruminococcus,
Eubacterium, Lactobacillus, Methanobrevibacter and
Sulfate-reducing bacteria (SRB).16S rRNA gene was tar-
geted for designing primers except for SRB (Table 1).
Sulphate reducing gene was targeted for quantifying
members of SRB. Primers were commercially obtained
from Sigma-aldrich, USA.13 14 15 16 17 18 19 20 21 22 23 24 24.5


















ap of EhRI episome (24.5 kb) showing the position of HMe probe (4.5
H- Hind III site; rDNA I and rDNA II represent two inverted repeats of
ive figure of Dot-blot analysis of stool sample using HMe probe. Rows
ng of DNA was loaded on each spot in triplicate on nylon membrane.
as positive control; (column B) E. dispar SAW760 genomic DNA as






















Figure 2 Screening of Stool samples by PCR. (A) Schematic representation of location of Entamoeba histolytica specific primer. BH16197 is
Genbank accession number of Entamoeba histolytica SINE-2 (EhSINE2) element; (B) Schematic representation of location of Entamoeba dispar
specific primer from rDNA molecule. 18 S, 5.8 S and 28 S are corresponding ribosomal gene sequences and ITS-1 and ITS-2 refers to internal
transcribed spacer 1 and 2; (C) Detection of E. histolytica in stool DNA sample using E. histolytica specific primers, Lane 1 =Marker 100 bp, Lane 2
= EhHM1 genomic DNA as positive control, Lane 3 & 4 stool sample DNA, Lane 5 = Genomic DNA of E. dispar SAW760 as negative control.
Sample in lane 4 is E. histolytica positive; (D) Detection of E. dispar in Stool sample using E. dispar specific primers. Lane 1 = Marker 1 kb, Lane
2,3,4 and 5 stool sample DNA, Lane 6 = Genomic DNA of E. dispar as positive control. Sample in Lane 3 and 5 are E. dispar positive. Lane 4 stool
sample is E. histolytica positive and was used as negative control.
Table 1 Genus specific 16S rRNA targeted bacterial primers used in this study
Sr no. Genus Primer sequence PCR Product (bp) Tm(ºC) References
1. Methanobrevibactr F 5’- CGATGCGGACTTGGTGTTG-3’ 184 59.7 [21]
R 5’-TGTCGCCTCTGGTGAGATGTC-3’ 59.8
2. Peptostreptococcus F 5’-AACTCCGGTGGTATCAGATG-3’ 270 55.4 [1]
R 5’-GGGGCTTCTGAGTCAGGTA-3’ 56.4
3. Ruminococcus F 5’-GAAAGCGTGGGGAGCAAACAGG-3’ 302 65.8 [21]
R 5’- GACGACAACCATGCACCACCTG-3’ 64.4
4. Eubacterium F 5’-GTAGTCCACGCCGTAAACGATG-3’ 278 60.4 [21]
R 5’-ACACGAGCTGACGACAACCATG-3’ 62.4
5. Bacteroides F 5’- GGGGTTCTGAGAGGAAG-3’ 115 54.0 [21]
R 5’- GCTACTTGGCTGGTTCAG-3’ 56.0
6. Lactobacillus F 5’-GCAGCAGTAGGGAATCTTCCA-3’ 340 64.0 [25]
R 5’-GCATTYCACCGCTACACATG-3’ 58.0
7. Clostridium leptum subgroup F 5’-CGTCAGCTCGTGTCGTGAGAT-3’ 125 60.0 [21]
R 5’-CGTCATCCCCACCTTCCTCC-3’ 62.5
8. Clostridium coccoides subgroup F 5’-GCCACATTGGGACTGAGA-3’ 170 56.0 This study
R 5’-GCTTCTTAGTCAGGTACCG-3’ 58.0
9. Campylobacter F 5’-AGGGAATATTGCGCAATGGGGGAAA-3’ 180 58.0 [21]
R 5’- GATTCCGAGTAACGCTTGCACCCT-3’ 59.0
10. Bifidobacterium F 5’-GATTCTGGCTCAGGATGAACGC-3’ 231 61.9 [21]
R 5’-CTGATAGGACGCGACCCCAT-3’ 60.8
11. Sulfate-reducing bacteria (APS reductase
subunit A gene)
F 5’-TGGCAGATMATGATYMACGG-3’ 396 54. This study
R 5’-GGCCGTAACCGTCCTTGAA-3’ 54.0
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Primers were designed from nim gene after Stephanie
Trinh et al. [14]. Primer sequences were as follows;
NIM-F (5’-ATGTTCAGAGAAATGCGGCGTAAGCG-3’)
and NIM-R (5’-GCTTCCTTGCCTGTCAT GTGCTC-3’).
Primers Nim-F and Nim-R designed by us amplify all
the members of nim gene family viz. nimA, nimB, nimC,
nimD and nimE. Primers were commercially synthesi-
zed from Sigma-Aldrich, USA. Primers NIM-F&R did
not amplify genomic DNA derived from axenic cul-
ture of E. histolytica HM1-IMSS [1] and blast result
of the selected primers did not show any homology
with E. histolytica genome. NIM-F&R primers ampli-
fied 458 bp fragment of nim gene from stool sample
DNA. This amplified fragment of 458 bp was cloned
in pGEMT-easy vector and sequenced to ensure the
amplification of correct gene. The clone was subsequently
used as a standard for quantification of nim gene by Real
Time-PCR.PCR-RFLP of nim gene
Primers NIM-F and NIM-R were used to amplify all the
members of nim gene family from stool sample DNA.
Members of nim gene family were differentiated by
digesting the PCR product with restriction enzymes
HpaII and TaqI. HpaII digests nimA, nimC, nimD at dif-
ferent loci but not nimB and nimE where as TaqI digests
nimA, nimB, nimE at different loci but not nimC and
nimD [19].Reference strains
Genus specific primers were used to amplify respected
genera from DNA of stool sample of healthy individual.
The amplified product was cloned and sequenced and
sequences were deposited in EMBL database to obtain the
accession numbers (Table 2).These 16S rRNA gene frag-
ment containing plasmids were used as reference strains.Table 2 Accession number of reference strain used in the
study
Bacteria Source Accession no.
Bacteroides Stool of healthy individual AM117604
Methanobrevibacter Stool of healthy individual FN813615
Eubacterium Stool of healthy individual FN813614
Lactobacillus Stool of healthy individual AM042701
Bifidobacterium Stool of healthy individual AM042698
Clostridium Stool of healthy individual AM042697
Campylobacter Stool of healthy individual AM042699
Ruminococcus Stool of healthy individual FN823053
Sulfate-reducing bacteria Stool of healthy individual FN995351Real time PCR analysis of bacterial population
Quantification was done using ABI-7500 machine and
power syber green PCR master mix kit from Applied
Biosystems, USA. Standard curve was the method of
choice for absolute quantification of bacteria. Standard
curve was made using serial dilutions of plasmid (con-
taining 16S rRNA gene fragment) of known concentra-
tions on tenfold basis. With the molecular weight of the
plasmid and insert known, it is possible to calculate the
copy number as follows:
Step 1: Determining molecular weight (mw)Weight in Daltons (g/mol) = (bp size of double
stranded product)(330 Da x 2nt/bp)Step 2: Molecular weight to copy numberX g/mol/Avogadro’s number (6.023 × 1023
molecules/mole) = X g/molecule
Where X = the weight of one molecule or copy
Where bp = base pairs, nt = nucleotides [20]Real time PCR runs were performed in 96 well optical
plates (each containing 1x PCR master mix, 4 pm/μl for-
ward and reverse primer(optimized concentration) and
1μl plasmid DNA of tenfold dilutions or 1μl DNA from
samples in 20μl reaction) for 40 cycles using an ABI
7500 sequence detector (Applied biosystems). Default
7500 cycle conditions were used with only change in the
annealing temperature. A standard curve was drawn by
plotting the natural log of the threshold cycle (Ct)
against the natural log of the number of molecules.
Melting curves were obtained from 55°C to 90°C, with
fluorescence measurements taken at every 1°C increase
in temperature. All reactions were carried out in tripli-
cate along with a non-template control. Ct values were
calculated under default settings for the absolute quanti-
fication using the software provided with the instrument.
The equation drawn from the graph was used to calcu-
late the precise number of target molecule (plasmid copy
no. or number of bacteria) tested in same reaction plate
as standard as well as in sample.Statistical analysis
Graph of respective bacterial population is plotted as
mean value with standard error. Each sample was ana-
lyzed in triplicate for calculation of significant differences
in bacterial population by the Man-Whitney test. P values
of 0.05 or below considered as significant. Paired samples
collected from healthy volunteers before and after satroni-
dazole treatment were analyzed by Wilcoxon matched-
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GraphPad Prism-5 software.
Results
Screening of E. histolytica positive samples
DNA from concentrated cyst was subjected to Dot-blot
hybridization. Dot blot analysis of 550 samples yielded 39
samples (7%) that were positive for Entamoeba (Figure 1B).
The DNA from Entamoeba positive samples were subjected
to PCR using species specific primers of E. histolytica and
E. dispar (Figure 2C & D). Out of 39 samples, 17 samples
(43%) were positive for E. histolytica. None of the samples
in our study population were found positive for both the
species of the parasite.
Quantification of predominant flora
High quality DNA isolated from E. histolytica positive stool
sample was subjected to Real Time analysis to assess the pre-
dominant gut flora that included Bacteroides, Bifidobacter-
ium, Eubacterium, Clostridium leptum subgroup, Clostridium
coccoides subgroup, Lactobacillus and Ruminococcus. Two
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Figure 3 Detemination of copy number of nimE gene by Real-time PC
efficiency. (B) Dissociation curve showing specific amplification of target (n
of copy no. of nimE gene in Healthy vs E. histolytica positive samples. (D
DNA of Healthy volunteers before and after satronidazole treatment. P v
confidence interval.reducing bacteria (SRB) were also quantified. Validation of
primers designed by us for the above genera have already
been reported [21]. In addition to the above primers, here we
report a Real time analysis of nim gene copy number for
which a standard curve and amplification curve have been
drawn that shows specific and efficient quantification with
slope =−3.6 and R2 =0.998 (Figure 3A & B).
Our analysis reveals that during healthy conditions,
the members of Bacteroides were the most abundant
in number among the predominant targeted genera.
However, a significant decrease was observed in
population of Bacteroides (p = .001) in E. histolytica
positive samples when compared to that of Healthy
control samples (Figure 4A). Simultaneously, we also
observed a significant decrease in the population of
Closrtridium coccoides subgroup (p = 0.002), Clostridium
leptum subgroup (p = 0.0001), Lactobacillus (p = 0.037),
Campylobacter (p = 0.0014) and Eubacterium (p = 0.038)
in E. histolytica positive samples in comparison to control
(Figure 4B, C, D, E and F respectively). Surprisingly,
we observed a significant rise in the population of







R. (A) Standard curve, slope = −3.6 and R2 = 0.998 showing good
imE gene) and NTC = No template control. (C) Absolute quantification
) Absolute quantification of copy no. of nimE gene in stool sample















Figure 4 Real-time analysis for quantification of different bacterial genera in Healthy vs E. histolytica positive (Eh + ve) samples. (A)
Bacteroides (B) Clostridium coccoides subgroup (C) Clostridium leptum subgroup (D) Lactobacillus (E) Campylobacter (F) Eubacterium. P value = .05 or
below was considered significant. CI stands for confidence interval.
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significant changes were observed in population of
Rumminococcus (p = 0.33) (Figure 5A). Though we did
not observe any significant change in the population of
Methanobrevibacter (p = 0.96) and Sulphur reducing
bacteria (p = 0.88) in amoebic samples but the prevalence
rate was reduced (Additional file 1: Figure S1A & B).
Copy no. of nim gene
We found the presence of nim genes in 72.7% of control
stool samples (n = 22) and in 41% of Entamoeba histolytica
infected patients (n = 17) by PCR (Figure 6A). Further the
amplified product was cloned and sequenced. BLAST ana-
lysis revealed 99% sequence homology with nimE gene
(Accession no. AM117602.1), a member of nim gene
family [22]. Subsequently, the PCR products from all the
samples of healthy and amebic individuals were subjected
to RFLP analysis using HpaII and TaqI restriction enzymes.
PCR-RFLP pattern confirmed the presence of only nimE
gene in all the samples analyzed (Figure 6B & C). Real time
analysis of nim gene in the stool samples exhibited sample
to sample variation (4 × 102 to 4 × 105 copies) in the bothcategory of samples. We observed a significant increase in
copy no. of nim gene in E. histolytica positive samples vs
samples from healthy persons (p = 0.025) (Figure 3C).
To see the effect of antiamoebic drug Satronidazole
(Alchem pharmaceuticals) on nim gene copy number,
healthy volunteers (n = 5) were advised to take the drug
(300 mg tablets) twice daily after meals for 4 days and
copy of nim gene was quantified before and after the
treatment using the primers described here. Wilcoxon
matched-pairs signed rank test (two tailed) analysis
of copy no. of nim gene shows no significant change
(p = 0.125) in stool samples collected before and after
treatment (Figure 3D).
Discussion
Infection by E. histolytica is normally initiated by the in-
gestion of fecally contaminated water or food containing
E. histolytica cysts. Phagocytosis of colonic bacteria has
been considered as a possible stimulus to induce the in-
vasive behavior by the parasite [23]. Adult gut micro-
biota are quite stable in individuals and can even be






Figure 5 Real-time analysis of population of (A) Rumminococcus in Healthy vs E. histolytica positive (Eh + ve) samples (B) Bifidobacterium in
Healthy vs E. histolytica positive (Eh + ve) samples. P value = .05 or below was considered significant. CI stands for confidence interval.
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and LPG only after the axenic E. histolytica had been
adapted to grow with bacterial flora for a number of
generatiom, and not in short term culture [26]. In
the present study we tried to evaluate perturbations in
commensal gut flora caused as result of E. histolytica in-
fection using Real Time PCR. qPCR methodology
is less expensive, more quantitative and is more effi-
cient in terms of time and operation [27]. The absolute
proportions of eight predominant commensal and two
subdominant genera were quantified successfully in our
samples.
Bacteroides species are a pleomorphic group of
non-spore forming gram-negative anaerobic bacteria.
Bacteroides are the most dominant part of the normal
indigenous flora in the human gut. Bacteroides are
mostly represented by Bacteroides ovatus, Bacteroides
uniformis Bacteroides vulgatus, Bacteroides thetaiotao-
micron, Bacteroides distasonis, and less frequently by
Bacteroides eggerthii and Bacteroides fragilis. These
bacteria are significant contributors to the carbohy-
drate metabolism, nutrition and health of humans
and animals. In 1999 Hooper et al. demonstrated that
B. thetaiotaomicron can modify intestinal fucosylation
in a complex interaction mediated by fucose repressor
gene and a signaling system [28]. The significant de-
crease in population of Bacteroides during disease
condition dampens the beneficial effects of this gen-
era to host.
In the human intestinal tract, Eubacterium is the se-
cond most common genus after the genus Bacteroides.
The genus Eubacterium comprises a nutritionally diverse
group of organisms. The members of genus Eubacterium
are known to produce butyrate [29], degrade flavonoids
(from vegetables, fruits, nuts, and tea) [30] and are
implicated in steroid and bile transformation in intestine[31]. The decrease in population of Eubacterium sp.
observed in our study may reduce the butyrate produc-
tion and may also affect the capacity of the host in
proper digestion of the above ingredients of food.
Bifidobacterium species are common inhabitants of
the gastrointestinal tract, and they have received
special attention because of their health-promoting
effects in humans. Members of Bifidobacteria produce
enough acetate (SCFA) in proximal and distal colon
by fermentation of glucose and fructose [32].
Members of both Bifidobacteria and Ruminococcus
-Ruminococcus torques and Bifidobacterium bifidum
are thought to ferment mucin and compete to colon-
ise this substrate for their energy source [33]. Our re-
sult shows a significant increase in population of
Bifidobacterium but no change in population of Rum-
minococcous despite decrease in population of several
other targeted genera. It is quite well known that
mucus secretion is increased in E. histolytica infection es-
pecially during dysentery which is probably result of a
mechanism exerted by intestinal epithelial cells to counter
the adherence of E. histolytica trophozoites to intestinal
epithelial surface. The protozoan parasite Entamoeba his-
tolytica cleaves Mucin 2 (MUC2) in the non-glycosylated
oligomerization domains by cysteine protease, thus break-
ing down the macromolecular structure and reducing
mucus viscosity [34]. Perhaps under this condition, a
cross-talk between the mucosal layer, bacteria and the
parasite initiates. As a result, the intestinal epithelial cells
tend to produce more of mucin for protection that pro-
motes colonization of Bifidobacteria in one hand and on
the other hand the parasite competes to more release of
mucin for its adhesion to epithelial layer. Bifidobacteria
longum are known to protect the gut from enteropatho-
genic infection through production of acetate [32] and
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Figure 6 Detection and identification of nim gene in stool samples. (A) Detection of nim gene using nim gene specific primers. Lane
1 =Marker 100 bp, Lane 2 = clone of nim gene as positive control, Lane 3–5 = DNA from stool samples from healthy volunteer, Lane 6–8 = DNA from
stool samples from E. histolytica positive patients and Lane 9 = No template control PCR (B) Restriction map of TaqI restriction sites in 458 bp nimE
gene fragment. (C) HpaII does not digest nimE,where as digestion of nimE by TaqI generates four fragment of 274 bp,155 bp,6 bp and 25 bp.
Lane 1 =Marker 100 bp, Lane H1, H2, E1 and E2 show RFLP profile of PCR product digested with HpaII; Lane H3, H4, E3 and E4 show RFLP profile of
PCR product digested with TaqI. H1-H4, DNA from stool samples of Healthy volunteers and E1-E4 are DNA from stool samples of E. histolytica positive patients.
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needed for healthy colon.
The C. leptum subgroup and C. coccoides subgroup are
one of the most predominant populations of human fecal
microflora which contains a large number of butyrate-
producing bacteria [35,36]. Butyrate is a SCFA (Short
chain fatty acids) having a strong effect on the cell cycle
and acts as anti-inflammatory molecule in the gut. Effects
on mucosal defense include improved tight junction as-
sembly, antimicrobial secretion and mucin expression
[37]. The decrease in population of members of C. leptum
subgroup and C. coccoides subgroup observed here leads
to decrease in the production of SCFA and hence renders
the host more susceptible for future infections.
The genus Lactobacillus comprises a large heterogenous
group of low G +C gram positive, non sporulating, anaer-
obic bacteria belonging to phylum Firmicutes. Lactobacilli
are known to fortify epithelial barrier by various mechan-
ism such as induction of mucin secretion, enhancement of
tight-junction functioning, upregulation of cytoprotective
heat shock proteins and prevention of apoptosis of
epithelial cells [38]. Probiotic strains of Lactobacillus are
known to prevent infectious diarrhea, antibiotic associated
diarrhea and diarrhea in children who are unusually more
susceptible as a result of poor nutrition, impaired immune
status or frequent exposure to pathogens [39]. Weobserved significant decrease in population of Lactobacillus
in gut flora of E. histolytica positive patients as compared
to that of healthy individuals that support our earlier obser-
vation made by semi quantitative method [1].
Methanobrevibacter smithii is the dominant archaeon in
human gut that affects the specificity and efficiency of
bacterial digestion of dietary polysaccharides, thereby
influencing host calorie harvest and adiposity [40]. It has
been suggested that the low and variable prevalence of
Methanobrevibacter smithii and Methanosphaera stadt-
manae DNA in human stool contrasts with the paramount
role of these methanogenic archaea in digestion processes
and hypothesized that this contrast is a consequence of
the inefficiencies of current protocols for archaea DNA ex-
traction [41]. In our samples prevalence of M. smithii in
healthy individuals stool samples was 27.27 % and that was
further reduced to 11.7 % in E. histolytica positive samples.
Real-time analysis shows no significant alteration in popu-
lation of M. smithii. Variation in the loads of M. smithii
under different pathophysiological condition such as dur-
ing amebiasis has not been reported so far.
Suphate reducing bacteria (SRB) are a group of non
spore forming, gram negative, dissimilatory sulphate re-
ducing, anaerobic bacteria. SRB can be isolated from the
intestinal tract of humans and various environmental
sources. Intestinal SRB’s growth and resultant hydrogen
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gastrointestinal tract and thereby contribute to chronic
intestinal disorders [42]. Desulfovibrio fairfieldensis and
D. desulfuricans have been associated with incidence of
bacteremia and D. vulgaris has been associated with
intra-abdominal infections [43]. The prevalence of
Sulphate reducing bacteria was 36.36% in healthy and
11.7% in amoebic individuals stool samples. However,
the change was not statistically significant.
The genus Campylobacter is notorious for causing
gastroenritis by C. jejuni but uncultured Campylobac-
ter species e.g. Campylobacter hominis whose role is
not clear yet, do exist in lower gastrointestinal tract
of healthy humans [44]. We observed significant de-
crease in population of Campylobacter in E. histoly-
tica positive individual as compared to healthy
individuals. As our primers were genus specific, so
decrease in Campylobacter was genera specific and
not species specific. Significant increase in the popu-
lation of Campylobacter has been observed in IBD
[21] but we did not find the same trend in amoebic
patients.
Several species of Bacteroides are known to harbor
nim genes e.g. B. fragilis, B. distasonis, B. thetaiotaomi-
cron, B. vulgatus, B. ovatus but wide differences in MIC
values of metronidazole are observed, ranging from 1.5
to >256 mg/L and some are also found above the
therapeutic breakpoint of 16 mg/L [45].Though the
population of Bacteroides is decreased significantly in E.
histolytica positive patients however we have observed
high copy no. of nimE gene in the same. We attribute
this increase to the presence of plasmid coded nimE
gene as has been observed earlier in Veillonella sp. [46].
Future analyses that target specific members of the Bac-
teroides group will shed further light on the species
involved in the expansion of nimE gene. In 2006, Rani
et al. reported presence of nim gene in stool samples of
amebic individuals but not in healthy individuals [1] but
our result show high prevalence rate of nim gene even
in healthy individuals irrespective of the disease.
However in a hospital based study carried out in Greece
revealed low level of prevalence of nim gene in isolates
of different anaerobic bacterial species from hospitalized
patients [47]. Though the presence of nim gene in gut
of healthy north Indian population is shocking but this
may be explained due to easy over the counter drug
availability in India. Results on healthy individuals
undergoing Satronidazole treatment indicate that nimE
gene copy number does not show significant reduction.
It can therefore be assumed that nimE gene harboring
Bacteroides probably cause inactivation of nitroimida-
zole drug and thereby reduce the bioavailability of drug
to the parasite and hence may help in sustaining
the infection.Conclusion
The metabolic activities of the predominant gut flora
have a significant effect on the health of the human
colon. The current findings of depleted populations of
metabolically important bacteria like Bacteroides, C.
leptum and C. coccoides sub groups, Lactobacillus sp.,
Eubacterium sp., and Campylobacter sp. add to our
knowledge of the changes in the GI tracts of amebic
patients. Such changes in bacterial population in the
normal microbiota could have considerable conse-
quences in terms of functional potential of gut flora and
could result in metabolic conditions favorable for the es-
tablishment of opportunistic pathogens (e.g. Clostridium
difficile). However, our study cannot conclude that
observed changes in the gut flora is the cause or effect of
the infection or the effect of dysenteric mechanism per se
by the parasite. Our findings could potentially guide imple-
mentation of dietary/probiotic interventions that impact
the gut microbiota and improve GI health in individuals
infected with Entamoeba histolytica.
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